Gadoteric acid
Description
Type: small molecule
Groups: approved
Indication: Not Available
Accession Number: DB09132 ( DB09132)
Description: Gadoteric acid is a macrocycle-structured gadolinium-based MRI contrast agent. It consists of the organic acid DOTA as a chelating agent, and gadolinium (Gd3+), and is used in form of the meglumine salt. The drug is approved and used in a number of countries worldwide. It is used to assist imaging of blood vessels and of inflamed or diseased tissue where the blood vessels become 'leaky'. It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood–brain barrier. Its paramagnetic property reduces the T1 relaxation time (and to some extent the T2 and T2* relaxation times) in NMR, which is the source of its clinical utility.
Structure:
Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Dotarem | injection | 376.9 mg/mL | intravenous | 20-03-2013 | 01-01-1970 | US |
Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Dotarem | injection | 376.9 mg/mL | intravenous | 20-03-2013 | 01-01-1970 | US |
Generic Prescription Products: Not Available
Over the Counter Products: Not Available
International Brands
- No Brands
Brand Names
- No Brands
Brand Mixtures
Brand Name | Ingredients |
---|---|
Dotarem | Gadoteric acid |
Brand Name | Ingredients |
---|---|
Dotarem | Gadoteric acid |
Categories
- No Category
Pharmacology
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half life: Not Available
Clearance: Not Available
Toxicity: Not Available
Affected organisms
- Not Available
SNP Mediated Adverse Drug Reactions
- Not Available
Pharmacoeconomics
- Not Available
Packagers:
- Not Available
Dosage forms
Form | Route | Strength |
---|---|---|
Injection | intravenous | 376.9 mg/mL |
Form | Route | Strength |
---|---|---|
Injection | intravenous | 376.9 mg/mL |
Prices
Unit description | Cost | Unit |
---|
Unit description | Cost | Unit |
---|
Patents
Country | Patent Number | Approved | Expires (estimated) |
---|
Interactions
Drug | Interaction |
---|
Drug | Interaction |
---|
Food Interactions:
- Not Available
Taxonomy
Super Class: Not Available
Class: Not Available
Sub Class: Not Available
Direct Parent: Not Available
Alternative Parents:
- Not Available
substituent:
- Not Available
References
General Reference: Not Available
External Links:
Resource | Link |
---|---|
Drugs.com | http://www.drugs.com/international/gadoteric-acid.html |
Resource | Link |
---|---|
Drugs.com | http://www.drugs.com/international/gadoteric-acid.html |
ATC Codes:
- Array
AHFS Codes:
- Not Available
MSDS: Download